You have selected the view in English
| Descriptor English: | Fas Ligand Protein | ||||||
| Descriptor Spanish: |
Proteína Ligando Fas
| ||||||
| Descriptor Portuguese: | Proteína Ligante Fas | ||||||
| Descriptor French: | Ligand de Fas | ||||||
| Entry term(s): |
Antigen, CD178 Antigens, CD178 CD178 Antigen CD178 Antigens CD95 Antigen Ligand CD95 Ligand CD95L Fas Ligand Fas Ligand (FasL) FasL Protein TNF Superfamily, Member 6 Tumor Necrosis Factor Ligand Superfamily Member 6 |
||||||
| Tree number(s): |
D12.644.276.374.750.249 D12.776.395.550.312 D12.776.467.374.750.249 D12.776.543.550.312 D23.529.374.750.249 |
||||||
| RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D053222 | ||||||
| Scope note: | A transmembrane protein belonging to the tumor necrosis factor superfamily that was originally discovered on cells of the lymphoid-myeloid lineage, including activated T-LYMPHOCYTES and NATURAL KILLER CELLS. It plays an important role in immune homeostasis and cell-mediated toxicity by binding to the FAS RECEPTOR and triggering APOPTOSIS. |
||||||
| Allowable Qualifiers: |
AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BI biosynthesis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis DE drug effects DF deficiency EC economics GE genetics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PH physiology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UL ultrastructure UR urine |
||||||
| Public MeSH Note: | 2007; FAS LIGAND PROTEIN was indexed under TUMOR NECROSIS FACTORS and MEMBRANE GLYCOPROTEINS 1994-2006 |
||||||
| History Note: | 2007(1994) |
||||||
| DeCS ID: | 52293 | ||||||
| Unique ID: | D053222 | ||||||
| Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
| Date Established: | 2007/01/01 | ||||||
| Date of Entry: | 2006/07/05 | ||||||
| Revision Date: | 2017/05/24 |
-
-
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins -
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins -
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins -
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins -
CHEMICALS AND DRUGS
Biological Factors [D23]Biological Factors
|
|
Fas Ligand Protein
- Preferred
| Concept UI |
M0229054 |
| Scope note | A transmembrane protein belonging to the tumor necrosis factor superfamily that was originally discovered on cells of the lymphoid-myeloid lineage, including activated T-LYMPHOCYTES and NATURAL KILLER CELLS. It plays an important role in immune homeostasis and cell-mediated toxicity by binding to the FAS RECEPTOR and triggering APOPTOSIS. |
| Preferred term | Fas Ligand Protein |
| Entry term(s) |
Antigen, CD178 Antigens, CD178 CD178 Antigen CD178 Antigens CD95 Antigen Ligand CD95 Ligand CD95L Fas Ligand Fas Ligand (FasL) FasL Protein TNF Superfamily, Member 6 Tumor Necrosis Factor Ligand Superfamily Member 6 |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey
